What is Vertex Pharmaceuticals's interest paid?

Vertex Pharmaceuticals (VRTX) reported interest paid of $3.00M in Q4 2025.

How has Vertex Pharmaceuticals's interest paid changed year-over-year?

Vertex Pharmaceuticals's interest paid increased by 11.1% year-over-year, from $2.70M to $3.00M.

What is the long-term trend for Vertex Pharmaceuticals's interest paid?

Over 4 years (2021 to 2025), Vertex Pharmaceuticals's interest paid has grown at a -31.5% compound annual growth rate (CAGR), from $56.30M to $12.40M.

What does interest paid mean?

The actual cash paid to lenders for interest on debt.

Discontinued — last reported Q3 '23

Supplemental

Interest Paid

Vertex Pharmaceuticals Interest Paid decreased by 6.3% to $3.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 11.1%, from $2.70M to $3.00M. Over 4 years (FY 2021 to FY 2025), Interest Paid shows a downward trend with a -31.5% CAGR. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementCash Flow Statement

SectionSupplemental

CategoryLeverage

SignalLower is better

VolatilityStable

First reportedQ4 2013

Last reportedQ3 2023

How to read this metric

An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.

Detailed definition

The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...

Peer comparison

Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.

Metric ID: cf_interest_paid

Historical Data

19 periods

	Q2 '21	Q3 '21	Q4 '21	Q1 '22	Q2 '22	Q3 '22	Q4 '22	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25
Value	$15.55M	$12.61M	$13.60M	$13.70M	$13.40M	$14.00M	$11.20M	$11.10M	$10.90M	$10.60M	$10.50M	$10.00M	$9.70M	$8.10M	$2.70M	$2.70M	$3.50M	$3.20M	$3.00M
QoQ Change	—	-18.9%	+7.8%	+0.7%	-2.2%	+4.5%	-20.0%	-0.9%	-1.8%	-2.8%	-0.9%	-4.8%	-3.0%	-16.5%	-66.7%	+0.0%	+29.6%	-8.6%	-6.3%
YoY Change	—	—	—	—	-13.8%	+11.0%	-17.7%	-19.0%	-18.7%	-24.3%	-6.3%	-9.9%	-11.0%	-23.6%	-74.3%	-73.0%	-63.9%	-60.5%	+11.1%

Range$2.70M – $15.55M

CAGR-30.6%

Avg YoY Growth-26.3%

Median YoY Growth-18.7%

Current Streak2 quarters decline

Interest Paid at Other Companies

AbbVieABBV View metric

PfizerPFE View metric

Johnson & JohnsonJNJ View metric

DanaherDHR View metric

StrykerSYK View metric

UnitedHealth GroupUNH View metric

Frequently Asked Questions

What is Vertex Pharmaceuticals's interest paid?: Vertex Pharmaceuticals (VRTX) reported interest paid of $3.00M in Q4 2025.
How has Vertex Pharmaceuticals's interest paid changed year-over-year?: Vertex Pharmaceuticals's interest paid increased by 11.1% year-over-year, from $2.70M to $3.00M.
What is the long-term trend for Vertex Pharmaceuticals's interest paid?: Over 4 years (2021 to 2025), Vertex Pharmaceuticals's interest paid has grown at a -31.5% compound annual growth rate (CAGR), from $56.30M to $12.40M.
What does interest paid mean?: The actual cash paid to lenders for interest on debt.